InsidersTradesSigma
Explore the full record of transactions filed by Hannah Brendan, Directeur Commercial. Officer active across 1 company, notably Cortexyme, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 19 May 2022. The latest transaction was filed on 19 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Hannah Brendan is the Chief Business Officer at Cortexyme, Inc. He is responsible for the company's business strategy, including business development and strategic partnerships to support growth.